Challenges and new technologies in adoptive cell therapy

P Zhang, G Zhang, X Wan - Journal of Hematology & Oncology, 2023 - Springer
Adoptive cell therapies (ACTs) have existed for decades. From the initial infusion of tumor-
infiltrating lymphocytes to the subsequent specific enhanced T cell receptor (TCR)-T and …

New approaches and procedures for cancer treatment: Current perspectives

DT Debela, SGY Muzazu, KD Heraro… - SAGE open …, 2021 - journals.sagepub.com
Cancer is a global health problem responsible for one in six deaths worldwide. Treating
cancer has been a highly complex process. Conventional treatment approaches, such as …

Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label …

FJ Smits, AC Henry, MG Besselink, OR Busch… - The Lancet, 2022 - thelancet.com
Background Early recognition and management of postoperative complications, before they
become clinically relevant, can improve postoperative outcomes for patients, especially for …

Characteristics of NH3/H2 blend as carbon-free fuels: A review

OI Awad, B Zhou, K Harrath, K Kadirgama - International Journal of …, 2023 - Elsevier
In the pursue of a carbon-free economy, the utilization of fuels with low or zero carbon
footprint account for only 1% of global final energy demand, a share that is predicted to …

Impact of malnutrition on early outcomes after cancer surgery: an international, multicentre, prospective cohort study

A Riad, SR Knight, D Ghosh, PA Kingsley… - The Lancet global …, 2023 - thelancet.com
Background Malnutrition represents a key priority for global health policy, yet the impact of
nutritional state on cancer surgery worldwide remains poorly described. We aimed to …

Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside

B Zhang, M Yang, W Zhang, N Liu, D Wang… - Cell Death & …, 2024 - nature.com
Immunotherapy has rapidly evolved in the past decades in the battle against cancer.
Chimeric antigen receptor (CAR)-engineered T cells have demonstrated significant success …

Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide

C Are, SS Murthy, R Sullivan, M Schissel… - The Lancet …, 2023 - thelancet.com
Summary The first Lancet Oncology Commission on Global Cancer Surgery was published
in 2015 and serves as a landmark paper in the field of cancer surgery. The Commission …

Financial toxicity in cancer care in India: a systematic review

JM Boby, S Rajappa, A Mathew - The Lancet Oncology, 2021 - thelancet.com
Although financial toxicity is widely acknowledged to be a potential consequence of costly
cancer treatment, little is known about its prevalence and outcome among the Indian …

Mobile devices and wearable technology for measuring patient outcomes after surgery: a systematic review

SR Knight, N Ng, A Tsanas, K Mclean, C Pagliari… - NPJ digital …, 2021 - nature.com
Complications following surgery are common and frequently occur the following discharge.
Mobile and wearable digital health interventions (DHI) provide an opportunity to monitor and …

The power of phages: revolutionizing cancer treatment

MS Islam, J Fan, F Pan - Frontiers in Oncology, 2023 - frontiersin.org
Cancer is a devastating disease with a high global mortality rate and is projected to increase
further in the coming years. Current treatment options, such as chemotherapy and radiation …